Cell survival characteristics of a human colon adenocarcinoma cell line after photodynamic treatment: a comparison of Photofrin II and TPPS.
dc.contributor.author | West, Catharine M L | |
dc.contributor.author | Moore, James V | |
dc.date.accessioned | 2010-11-03T10:34:09Z | |
dc.date.available | 2010-11-03T10:34:09Z | |
dc.date.issued | 1988-10 | |
dc.identifier.citation | Cell survival characteristics of a human colon adenocarcinoma cell line after photodynamic treatment: a comparison of Photofrin II and TPPS. 1988, 54 (4):621-34 Int. J. Radiat. Biol. | en |
dc.identifier.issn | 0955-3002 | |
dc.identifier.pmid | 2902160 | |
dc.identifier.doi | 10.1080/09553008814552061 | |
dc.identifier.uri | http://hdl.handle.net/10541/114429 | |
dc.description.abstract | A comparison has been made of the in vitro light-activated drug cytotoxicities of two different porphyrin compounds, Photofrin II and TPPS4. An early passage human colon adenocarcinoma cell line, WiDr, has been exposed to either drug for 24 h, the excess drug washed from the cells and the cells irradiated with light using quartz-tungsten-halogen lamps. Neither light nor drug alone under the experimental conditions employed was toxic to WiDr cells. Together, considerable cytotoxicity could be seen and the shapes of the cell survival curves following exposure to either drug then irradiation with light, were similar. For equal amounts of drug in the medium, Photofrin II was a more efficient photosensitizer of WiDr cells than TPPS4, and differences in cellular uptake could only partly explain this. When the experimental procedure was changed by reducing the temperature of irradiation, a reduction in photosensitizing efficiency could be demonstrated. This was more pronounced for Photofrin II, and was seen as a change in the slope of the final portion of the survival curve; and as a change in the shoulder for TPPS4. Two different batches of the two drugs were compared and shown to give slightly different results for Photofrin II (change in shoulder) but not to differ for TPPS4. | |
dc.language.iso | en | en |
dc.subject | Colonic Cancer | en |
dc.subject | Cultured Tumour Cells | en |
dc.subject | Haematoporphyrins | en |
dc.subject.mesh | Adenocarcinoma | |
dc.subject.mesh | Cell Survival | |
dc.subject.mesh | Colonic Neoplasms | |
dc.subject.mesh | Dihematoporphyrin Ether | |
dc.subject.mesh | Hematoporphyrins | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Light | |
dc.subject.mesh | Photochemotherapy | |
dc.subject.mesh | Porphyrins | |
dc.subject.mesh | Radiation-Sensitizing Agents | |
dc.subject.mesh | Temperature | |
dc.subject.mesh | Tumor Cells, Cultured | |
dc.title | Cell survival characteristics of a human colon adenocarcinoma cell line after photodynamic treatment: a comparison of Photofrin II and TPPS. | en |
dc.type | Article | en |
dc.contributor.department | Radiobiology Department, Paterson Institute for Cancer Research, Christie Hospital, Manchester, U.K. | en |
dc.identifier.journal | International Journal of Radiation Biology | en |
html.description.abstract | A comparison has been made of the in vitro light-activated drug cytotoxicities of two different porphyrin compounds, Photofrin II and TPPS4. An early passage human colon adenocarcinoma cell line, WiDr, has been exposed to either drug for 24 h, the excess drug washed from the cells and the cells irradiated with light using quartz-tungsten-halogen lamps. Neither light nor drug alone under the experimental conditions employed was toxic to WiDr cells. Together, considerable cytotoxicity could be seen and the shapes of the cell survival curves following exposure to either drug then irradiation with light, were similar. For equal amounts of drug in the medium, Photofrin II was a more efficient photosensitizer of WiDr cells than TPPS4, and differences in cellular uptake could only partly explain this. When the experimental procedure was changed by reducing the temperature of irradiation, a reduction in photosensitizing efficiency could be demonstrated. This was more pronounced for Photofrin II, and was seen as a change in the slope of the final portion of the survival curve; and as a change in the shoulder for TPPS4. Two different batches of the two drugs were compared and shown to give slightly different results for Photofrin II (change in shoulder) but not to differ for TPPS4. |